Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of “Hold” from Brokerages

Shares of Certara, Inc. (NASDAQ:CERT) have been assigned an average rating of “Hold” from the eleven research firms that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $20.06.

Several analysts have recently weighed in on the company. JMP Securities assumed coverage on Certara in a report on Thursday, April 4th. They issued a “market perform” rating for the company. SVB Leerink began coverage on Certara in a report on Monday, February 26th. They issued a “market perform” rating and a $19.00 price objective for the company. UBS Group upped their target price on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a report on Friday, March 1st. KeyCorp raised Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a report on Wednesday, April 10th. Finally, Barclays upped their price target on Certara from $16.00 to $18.00 and gave the company an “equal weight” rating in a research report on Thursday, January 25th.

Insiders Place Their Bets

In other Certara news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now owns 173,524 shares in the company, valued at approximately $3,123,432. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total value of $243,094.95. Following the sale, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. Insiders have sold a total of 23,427 shares of company stock valued at $405,095 in the last three months. Insiders own 2.60% of the company’s stock.

Institutional Trading of Certara

Large investors have recently made changes to their positions in the stock. Pineridge Advisors LLC bought a new stake in shares of Certara in the 4th quarter worth approximately $28,000. Global Retirement Partners LLC raised its holdings in shares of Certara by 5,306.3% in the 1st quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock worth $31,000 after buying an additional 1,698 shares in the last quarter. Covestor Ltd raised its holdings in shares of Certara by 14,940.0% in the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after buying an additional 3,735 shares in the last quarter. Gamco Investors INC. ET AL acquired a new position in shares of Certara in the 3rd quarter worth approximately $145,000. Finally, NorthRock Partners LLC acquired a new position in shares of Certara in the 3rd quarter worth approximately $168,000. Institutional investors own 73.96% of the company’s stock.

Certara Price Performance

Shares of CERT opened at $16.45 on Thursday. The company has a market cap of $2.64 billion, a P/E ratio of -47.00, a PEG ratio of 1.67 and a beta of 1.63. The stock has a fifty day moving average price of $17.76 and a 200 day moving average price of $16.22. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.62 and a quick ratio of 2.62. Certara has a 12 month low of $11.81 and a 12 month high of $24.70.

Certara (NASDAQ:CERT) last announced its quarterly earnings results on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. The business had revenue of $88.01 million for the quarter, compared to analyst estimates of $86.80 million. On average, research analysts forecast that Certara will post 0.29 earnings per share for the current year.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.